Annals of Clinical Biochemistry > Volume 46, Number 2 > Pp. 93-98

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: acb.2008.008113v1 46/2/93    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Waise, A. Articles by Price, H. C Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Personal View

The upper limit of the reference range for thyroid-stimulating hormone should not be confused with a cut-off to define subclinical hypothyroidism

Ahmed Waise^1,2 and Hermione C Price²

¹ Laboratory Medicine; ² Centre for Diabetes and Endocrinology, York Hospital, York YO31 8HE, UK

Corresponding author: Ahmed Waise. Email: ahmed.waise{at}nhs.net

The upper limit of the reference range for serum thyroid-stimulating hormone (TSH) is used to assist in identifying individuals with hypothyroidism. Improvements in TSH assays have led to better definition of the lower limit of the reference range, but the upper limit of the range for a healthy population is currently a topic of some debate. Population studies have improved our understanding of the clinical implications of elevated serum TSH concentrations in terms of future progression to hypothyroidism, but have not yet fully elucidated the correlation of modestly elevated TSH levels with long-term morbidity. This paper will review the current debate including the arguments for and against reducing the upper limit of the TSH range, whether such a level should be based on evidence from epidemiological studies, and the implications of categorizing large numbers of people with subclinical hypothyroidism. The impact of using different methodologies for the measurement of TSH and the inherent variability of results on reference ranges is also discussed. We argue that the reference range for TSH should be assay-specific and be determined by standard techniques in normal populations as recommended by the National Academy of Clinical Biochemistry. In contrast, we suggest that a decision level be determined separately from epidemiological studies to identify a population with subclinical hypothyroidism. Serial monitoring of TSH in this population deserves further study as a means of identifying those at risk of progressing to frank hypothyroidism and meriting treatment.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. A A Ismail Thyroid stimulating hormone cut-off to define subclinical hypothyroidism Ann Clin Biochem, September 1, 2009; 46(5): 426 - 426. [Full Text] [PDF]